My coach is excellent. He is helping me with my A1C, cortisol, and weight loss journey.
Wegovy® Pill with Ongoing Care
A once-daily oral GLP-1 tablet with up to 14% weight loss at one year. Prescribed through a Healthspan Membership with clinician-led evaluation and ongoing care to manage dosing, labs, and long-term health.
Your provider will review your medical history and goals to determine eligibility. If prescribed, medication is billed separately and fulfilled through NovoPharmacy.
Your care team manages dosing and tolerance, reviews labs, and provides guidance on nutrition and strength to support safe, sustainable progress.
Regular check-ins and labs track 70+ biomarkers beyond weight, including metabolic health, body composition, lean muscle, and sleep.
NEW FORMULATION
Wegovy® is now available as a once-daily oral pill
FDA-approved oral GLP-1
Easy, once-daily pill
~14% weight loss at 1 year (similar to injectable)
No injections or refrigeration needed
Prescription & ongoing care through Healthspan
1 Based on the 64-week OASIS 4 Phase 3 clinical trial of 307 adults with obesity or overweight. Average weight loss of 14% (13.6%) with oral semaglutide 25 mg vs. 2.4% with placebo, when used with diet and exercise. Wharton S, et al. N Engl J Med. 2025.
How ongoing care shapes GLP-1 outcomes
2x
Longer on therapy
Ongoing support keeps patients on GLP-1s 2x longer, maximizing long-term benefits
9+
Systems affected
GLP-1s influence brain, heart, kidney, & more. Tracking biomarkers across these systems enables better care
85%+
Muscle mass preserved
With guidance, patients preserve lean muscle through targeted protein and strength protocols
0-6 mo.
Critical adjustment period
Early months require guidance for dosing, tolerance, & progress for long-term success
Most GLP-1 programs stop at the prescription
Ours starts there
your complete care
Your personalized GLP-1 care starts with membership
Clinician-guided GLP-1 treatment
Your clinician reviews your medical history and goals to determine eligibility and guide the right treatment choice, including injectable or oral options.
Supporting brain function
GLP-1s cross the blood–brain barrier and have been studied for effects on neuroinflammation, mood regulation, and cognitive resilience, with early evidence suggesting neuroprotective potential.
Protecting cardiovascular health
Large outcome trials show reductions in major adverse cardiac events, linked to improved endothelial function, lower inflammation, and favorable lipid and blood pressure changes.
Supporting kidney function
GLP-1s have been associated with reduced albuminuria and slower progression of diabetic kidney disease in some populations.
Improving liver health
GLP-1s are well studied in NAFLD and NASH, with evidence showing reductions in liver fat and improvements in insulin sensitivity and liver enzymes.
Supporting PCOS & fertility
GLP-1 therapy has been associated with improvements in insulin resistance, ovulatory function, and androgen levels in individuals with PCOS, with emerging evidence for fertility benefits.
Reducing chronic inflammation
GLP-1 signaling has been linked to lower systemic inflammation, including reductions in CRP and improvements in endothelial and neuroinflammatory markers.
Improving body composition
GLP-1s influence fat loss and visceral fat reduction while impacting appetite regulation and metabolic efficiency; preserving lean mass remains a key clinical consideration.
Supporting respiratory health
Tirzepatide has been studied for weight-related obstructive sleep apnea, showing clinically meaningful reductions in apnea–hypopnea index.
Hear from our patients
Frequently asked questions
Healthspan offers an online, clinician-led GLP-1 care program designed for more than weight loss alone. A licensed clinician reviews your medical history, symptoms, and goals to determine whether the oral Wegovy® pill is appropriate for you. If prescribed, care continues with personalized dosing, side-effect management, and ongoing support as your body adapts to therapy. Medication is fulfilled separately through Novo Pharmacy. Your Healthspan membership covers the clinical oversight and care model that supports safe, effective GLP-1 use over time.
Both the pill and injectable versions of Wegovy® contain semaglutide, the active GLP-1 receptor agonist that helps regulate appetite, insulin signaling, and metabolic function. The difference is not the medication itself, but how it’s delivered and absorbed by the body. The pill version of Wegovy® is taken daily and absorbed through the digestive tract, while injectable GLP-1 medications deliver semaglutide through a weekly injection. Because absorption differs, oral semaglutide requires careful dosing and timing, and some people experience side effects differently than with injections. For this reason, Healthspan pairs the Wegovy® pill with clinician-guided dosing, side-effect management, and ongoing support to ensure the therapy is used safely and effectively over time.
The GLP-1 membership is designed to support GLP-1 therapy as ongoing medical care, not a one-time prescription. Membership includes clinician evaluation and prescribing, personalized dosing and titration over time, and continued clinical oversight as your body responds to treatment. Members also receive support for side-effect management, nutrition as appetite changes, and muscle-preservation strategies to support long-term metabolic health. The membership includes ongoing biomarker and lifestyle tracking, with labs incorporated into care when clinically appropriate to monitor metabolic health and guide treatment decisions over time. Labs are not required to start treatment, but are an important part of Healthspan’s longevity-focused approach as therapy progresses. Membership starts at $99 per month. GLP-1 medications are billed separately based on the prescription and pharmacy used. As part of the membership, Healthspan helps coordinate prescriptions, refills, and medication logistics as treatment evolves.
No. Healthspan clinicians prescribe GLP-1 therapy for a range of health goals, not weight loss alone. GLP-1s are increasingly used to support: metabolic health and insulin sensitivity; cardiometabolic risk reduction; appetite regulation and energy balance; long-term health and aging-related outcomes. Your clinician evaluates your goals and health context to determine which GLP-1 treatment option is appropriate and how it should be managed over time.
Yes. Many members come to Healthspan after starting a GLP-1 medication elsewhere and want to switch formats or refine how their care is managed. A licensed clinician will review your current GLP-1 medication, dosing history, tolerance, and goals to determine whether switching to the Wegovy® pill is appropriate. If a switch makes sense, your clinician will guide the transition carefully, including dose adjustments and side-effect management, to support a smooth change without disrupting progress. Healthspan membership provides ongoing clinical oversight, refill coordination, and support as treatment evolves, whether you’re continuing therapy, switching formats, or adjusting dosing over time.
Like all GLP-1 medications, the Wegovy® pill (oral semaglutide) can cause side effects, particularly during early treatment or when doses change. The most common side effects include nausea, gastrointestinal discomfort, changes in appetite, and feeling full more quickly. These effects are typically temporary and improve as the body adjusts. Healthspan’s care model is designed to help minimize side effects through personalized dosing, gradual titration, and clinician guidance. If side effects occur, your clinician can adjust dose timing, pace of increases, or supportive strategies to improve tolerance. Ongoing membership ensures you’re not managing symptoms alone and that treatment remains aligned with your health goals over time.
Healthspan offers an online, clinician-led GLP-1 care program designed for more than weight loss alone. A licensed clinician reviews your medical history, symptoms, and goals to determine whether the oral Wegovy® pill is appropriate for you. If prescribed, care continues with personalized dosing, side-effect management, and ongoing support as your body adapts to therapy. Medication is fulfilled separately through Novo Pharmacy. Your Healthspan membership covers the clinical oversight and care model that supports safe, effective GLP-1 use over time.
Both the pill and injectable versions of Wegovy® contain semaglutide, the active GLP-1 receptor agonist that helps regulate appetite, insulin signaling, and metabolic function. The difference is not the medication itself, but how it’s delivered and absorbed by the body. The pill version of Wegovy® is taken daily and absorbed through the digestive tract, while injectable GLP-1 medications deliver semaglutide through a weekly injection. Because absorption differs, oral semaglutide requires careful dosing and timing, and some people experience side effects differently than with injections. For this reason, Healthspan pairs the Wegovy® pill with clinician-guided dosing, side-effect management, and ongoing support to ensure the therapy is used safely and effectively over time.
The GLP-1 membership is designed to support GLP-1 therapy as ongoing medical care, not a one-time prescription. Membership includes clinician evaluation and prescribing, personalized dosing and titration over time, and continued clinical oversight as your body responds to treatment. Members also receive support for side-effect management, nutrition as appetite changes, and muscle-preservation strategies to support long-term metabolic health. The membership includes ongoing biomarker and lifestyle tracking, with labs incorporated into care when clinically appropriate to monitor metabolic health and guide treatment decisions over time. Labs are not required to start treatment, but are an important part of Healthspan’s longevity-focused approach as therapy progresses. Membership starts at $99 per month. GLP-1 medications are billed separately based on the prescription and pharmacy used. As part of the membership, Healthspan helps coordinate prescriptions, refills, and medication logistics as treatment evolves.
No. Healthspan clinicians prescribe GLP-1 therapy for a range of health goals, not weight loss alone. GLP-1s are increasingly used to support: metabolic health and insulin sensitivity; cardiometabolic risk reduction; appetite regulation and energy balance; long-term health and aging-related outcomes. Your clinician evaluates your goals and health context to determine which GLP-1 treatment option is appropriate and how it should be managed over time.
Yes. Many members come to Healthspan after starting a GLP-1 medication elsewhere and want to switch formats or refine how their care is managed. A licensed clinician will review your current GLP-1 medication, dosing history, tolerance, and goals to determine whether switching to the Wegovy® pill is appropriate. If a switch makes sense, your clinician will guide the transition carefully, including dose adjustments and side-effect management, to support a smooth change without disrupting progress. Healthspan membership provides ongoing clinical oversight, refill coordination, and support as treatment evolves, whether you’re continuing therapy, switching formats, or adjusting dosing over time.
Like all GLP-1 medications, the Wegovy® pill (oral semaglutide) can cause side effects, particularly during early treatment or when doses change. The most common side effects include nausea, gastrointestinal discomfort, changes in appetite, and feeling full more quickly. These effects are typically temporary and improve as the body adjusts. Healthspan’s care model is designed to help minimize side effects through personalized dosing, gradual titration, and clinician guidance. If side effects occur, your clinician can adjust dose timing, pace of increases, or supportive strategies to improve tolerance. Ongoing membership ensures you’re not managing symptoms alone and that treatment remains aligned with your health goals over time.
